The conditional offer represents US$119 million in revenue over the next four years.
A public investment company focused on economic development in the Tairawhiti is taking its first offer on a local roadshow this week.
Hikurangi Group and Rhizo Sciences intend to establish the first pharmaceutical grade GMP medical cannabis production and processing facility in New Zealand.
Waiapu Investments Limited is a new investment company created by charitable company Hikurangi Enterprises to enable members of our community and supporters everywhere to have a real stake in the ventures Hikurangi Group is developing. Hikurangi Group includes a number of commercial entities with a focus on truly sustainable economic development for the East Coast…
“The last thing legitimate growers need is this kind of cavalier fly-boy approach by a small group of public servants who are supposed to enforce the law, not break it.”
New law will see domestic production enabled and more affordable access for patients.
Hikurangi to research kānuka genetics, optimal planting and growing conditions for bioactives.
E hoa ma, inā te ora o te tangata – Friends, this is the essence of life Our guiding whakatauki for Inā te Ora is sometimes used at the dinner table by guests appreciative of a good meal. Food is indeed the essence of life, it is crucial we move into the future with…
Sign up here if you’re interested in our 2018 cultivation course.
Fruit peel waste as a source of high value pharmaceutical drugs and agricultural chemicals?!
A unique opportunity for Māori land blocks to access specialists at top R&D organisations.
Join us to explore the future of food production in Tairāwhiti!